Clinical considerations in Parkinson's disease cell therapy

被引：6

作者：

Xue, Jun ^{[1
,2
]}

Wu, Yifan ^{[1
,2
]}

Bao, Yuting ^{[1
,2
]}

Zhao, Minglai ^{[1
,2
]}

Li, Fangzhou ^{[1
,2
]}

Sun, Jing ^{[3
]}

Sun, Yimin ^{[4
]}

Wang, Jian ^{[4
]}

Chen, Liang ^{[1
,2
]}

Mao, Ying ^{[1
,2
]}

Schweitzer, Jeffrey S. ^{[5
]}

Song, Bin ^{[1
,2
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China

[2] Fudan Univ, Shanghai Clin Med Ctr Neurosurg, Neurosurg Inst,Shanghai Key Lab Brain Funct & Res, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China

[3] Fudan Univ, MOE Frontiers Ctr Brain Sci, Inst Translat Brain Res, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China

[4] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Inst Neurol,Natl Clin Res Ctr Aging & Med, Shanghai 200032, Peoples R China

[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA

来源：

AGEING RESEARCH REVIEWS | 2023年 / 83卷

基金：

上海市自然科学基金; 中国国家自然科学基金;

关键词：

Parkinson?s disease; Cell therapy; Dopamine cells; Transplantation; Clinical trial; FETAL DOPAMINE NEURONS; IMPROVES XENOGRAFT SURVIVAL; GRAFT-INDUCED DYSKINESIAS; RIGHT CAUDATE-NUCLEUS; LONG-TERM SURVIVAL; MESENCEPHALIC TISSUE; PRIMATE MODEL; NIGRAL TRANSPLANTATION; GENE-THERAPY; NEURAL PROGENITORS;

D O I：

10.1016/j.arr.2022.101792

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cell replacement therapy is an area of increasing interest for treating Parkinson's disease (PD). However, to become a clinically practical option for PD patients, it must first overcome significant barriers, including establishment of safe and standardized surgical procedures, determination of appropriate perioperative medication regimens, demonstration of long-term graft survival and incorporation, and standardized, clinically meaningful follow-up measures. In this review, we will describe the current status of cell therapy for PD with special attention to these critical requirements, to define guideposts on the road to bring the benefit of this therapy to the Parkinson's clinic.

引用

页数：20

共 50 条

[31] Improved Delivery Methods for Gene Therapy and Cell Transplantation in Parkinson's Disease
Larson, Paul S.
JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S199 - S206
[32] Advances in stem-cell-generated transplantation therapy for Parkinson's disease
Sundberg, Maria
Isacson, Ole
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 437 - 453
[33] Clinical and economic analysis of spa therapy in Parkinson's disease
Brefel-Courbon, C
Desboeuf, K
Thalamas, C
Galitzky, M
Senard, JM
Rascol, O
Montastruc, JL
MOVEMENT DISORDERS, 2003, 18 (05) : 578 - 584
[34] Cell Therapeutics in Parkinson's Disease
Lindvall, Olle
Bjorklund, Anders
NEUROTHERAPEUTICS, 2011, 8 (04) : 539 - 548
[35] Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells
Clark, Branden J.
Lelos, Mariah J.
Loring, Jeanne F.
STEM CELLS, 2024, 42 (09) : 781 - 790
[36] Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts
Wenker, Shirley D.
Celeste Leal, Maria
Isabel Farias, Maria
Zeng, Xianmin
Pitossi, Fernando J.
BRAIN RESEARCH, 2016, 1638 : 15 - 29
[37] Human embryonic stem cell therapy for Parkinson's disease
Ben-Hur, Tamir
FUTURE NEUROLOGY, 2006, 1 (02) : 227 - 236
[38] Novel Approach to Stem Cell Therapy in Parkinson's Disease
Garitaonandia, Ibon
Gonzalez, Rodolfo
Sherman, Glenn
Semechkin, Andrey
Evans, Andrew
Kern, Russell
STEM CELLS AND DEVELOPMENT, 2018, 27 (14) : 951 - 957
[39] Stem Cell Transplantation: A Promising Therapy for Parkinson’s Disease
Yi Wang
Sheng Chen
Dehua Yang
Wei-dong Le
Journal of Neuroimmune Pharmacology, 2007, 2 : 243 - 250
[40] Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis
Fang Wang
Zhengwu Sun
Daoyong Peng
Shikha Gianchandani
Weidong Le
Johannes Boltze
Shen Li
Journal of Translational Medicine, 21

← 1 2 3 4 5 →